The nitric oxide synthases are large, modular, dimeric enzymes composed of a reductase domain, which is related to cytochrome P450 reductase, and a structurally unique oxygenase domain containing a Cys-ligated haem. Both the neuronal and endothelial isoforms are activated by the reversible binding of calmodulin (CaM) at elevated intracellular Ca 2+ levels to produce NO as part of a number of cell signalling pathways. CaM binds to the linker region between the two domains and activates the enzyme by inducing intramolecular electron transfer. Protein-engineering experiments have shown that a series of unusual autoinhibitory inserts found only in the CaM-dependent NOS isoforms control both CaM binding and the structural rearrangement it induces. These lie in the reductase domain of the enzyme and include a 40-amino-acid autoinhibitory loop in the FMN-binding module, a 30-amino-acid extension to the C-terminus and the CaM-binding site itself. The substrate (NADPH) also plays an important role in defining the CaM-dependence of the reductase domain by inducing a tight conformational lock in the absence of CaM. Both the substrate and the conformational lock appear to be released on CaM binding; the resultant domain mobility leads to activation.
Introduction
The mammalian nitric oxide synthases (NOSs) are homodimeric flavocytochromes which bind stoichiometric quantities of haem, FMN, FAD and (6R)-5,6,7,8-tetrahydro-L-biopterin (H 4 B) [1] . They catalyse the synthesis of NO and citrulline from L-arginine via two consecutive monooxygenation reactions. Each subunit of NOS consists of a unique haem/H 4 B-binding oxygenase domain and an FAD/FMN-binding reductase domain. The latter is closely related to mammalian cytochrome P450 reductase and supplies electron equivalents to the oxygenase domain of the other subunit ( Figure 1 ). The three main isoforms of NOS are each expressed in specific cell types and are designated neuronal (nNOS), endothelial (eNOS) and macrophage or inducible (iNOS), although expression is not limited solely to these locations. The NO generated by the three different isoforms is involved, respectively, in neurotransmission, regulation of blood flow/pressure and the immune response. nNOS and eNOS generate NO to act as a signalling molecule, targeting guanylate cyclase, whereas iNOS produces large amounts of NO to attack proteins and DNA either directly or as peroxynitrite, following combination with superoxide. The constitutive NOSs (nNOS and eNOS) are regulated by the reversible binding of calmodulin (CaM) through changes in the intracellular Ca 2+ concentration, whereas iNOS is expressed with CaM bound permanently and remains active in the absence of free Ca 2+ . In all three isoforms, CaM binds to the protein linker connecting the two domains and regulates the activity of the enzyme by activating FMN-to-haem electron transfer [2] . CaM also activates the reductase domain independently towards reduction of artificial electron acceptors; both mechanisms are thought to result from large-scale conformational changes on CaM binding, which has no effect on the redox properties of the enzyme's flavin cofactors [3] .
Autoinhibition in NOS
Despite the high degree of sequence identity between the NOS isoforms (50-60%), certain notable regions of largescale heterogeneity exist. Firstly, the nNOS isoform contains an N-terminal extension of some 200 amino acids leading into the oxygenase domain, which is not present in the other isoforms. This is a PDZ-binding domain that is thought to anchor the enzyme to specific intracellular locations. X-ray crystal structures have been determined for the isolated oxygenase domains of all three isoforms and these are remarkably similar. However, the sequences diverge again over the interdomain linker, which forms the CaM-binding site. The three isoforms have very different levels of Ca 2+ dependence, with iNOS being largely immune to Ca 2+ concentration variations and nNOS and eNOS being inactivated at different threshold levels. Studies involving the creation of NOS chimaeric enzymes indicate that enzymes containing the iNOS CaM-binding site have a stronger affinity for CaM, but do not, like wild-type iNOS, bind CaM irreversibly. This has implicated regions of the reductase domain in the control of CaM binding [1, 4] . In the middle of the FMN-binding subdomains of nNOS and eNOS, a region related to the ubiquitous electron-transfer protein flavodoxin, lies an insert 40-50 amino acids in length. The insert marks a large structural divergence by these two isoforms from iNOS, cytochrome P450 reductase and flavodoxin. Salerno et al. [5] showed that peptides based on the sequence of the eNOS insert could inhibit NO synthesis in both eNOS and nNOS, but not in iNOS. The peptides were shown to compete directly with CaM binding. The role of the insert was further assessed by the construction of deletion mutants of both eNOS and nNOS [6, 7] . The eNOS mutant was found to have a lower Ca 2+ /CaM-binding threshold, but was inactive in the absence of CaM. The nNOS mutant ( 40) also had a lower Ca 2+ /CaM-binding threshold, but retained 30% of its activity in the absence of CaM (Table 1) . These results indicate that the insert performs an autoinhibitory function in both enzyme forms by interfering with CaM binding, and in the case of nNOS by directly inhibiting FMN-to-haem electron transfer. A further autoinhibitory region was also discovered at the C-termini of nNOS and eNOS. Deletion of these 21-42-amino-acid extensions had a similar effect to the insert deletions, in that the Ca 2+ /CaM-binding threshold of the mutants was lowered [8] . Both the eNOS and nNOS truncation mutants (nNOStr) were also found to retain NOS activity in the absence of CaM (Table 1) , much like the 40 mutant. Recently, a third form of nNOS displaying CaM-free NOS activity has been reported. In this mutant (F1395S) the FAD stacking residue, which is thought to flip into an alternative position on NADPH binding, has been replaced by serine. Interestingly, this residue lies immediately before the C-terminal extension, suggesting that the two may form part of the same mechanistic tool [9] .
Steady-state kinetic rate constants for nNOS and the three mutant forms with CaM-free activity are shown in Table 1 , along with data for the isolated nNOS reductase domain (nNOSrd) and a mutant that does not bind FMN (Y889A). The nNOSrd has similar rates of cytochrome c and ferricyanide reduction as the wild-type enzyme and similar Ca 2+ /CaM dependence [10, 11] . The machinery required to activate the enzyme appears, therefore, to be contained in the reductase half of the enzyme. It is notable that the three mutants with CaM-free NOS activity also have higher rates of CaM-free cytochrome c reductase activity. For the nNOStr mutant, CaM binding even represses cytochrome c reduction [8] . Ferricyanide reduction is also Ca 2+ /CaM-dependent in the wild-type enzyme and nNOSrd, but not in the mutants. Interestingly, loss of FMN on mutation of the FMN stacking residue Tyr-889 also abolishes CaM dependence [7] . The Y889A mutant, like nNOStr, is inhibited by CaM binding. All these mutations (and many others not included here) appear to enhance the reductase activity of the CaM-free enzyme; in a small number of cases this has also been linked to reactivation of NO synthesis [7] [8] [9] . The CaM-free form of the enzyme appears, therefore, to be kinetically repressed, and CaM binding, rather than simply reorienting the reductase domain, appears to relieve this repression. The FMN module insert and the C-terminal extension are both autoinhibitory control elements required to switch off the enzyme in the absence of CaM and to regulate CaM binding. The FAD stacking residue Phe-1395 and the FMN also appear to be important elements of the repression mechanism. The fact that mutation of any one of these appears to reactivate the reductase domain indicates that they are all acting in concert, suggesting that a particular inactive conformation of the enzyme is being stabilized.
Pre-steady-state kinetic analysis of nNOSrd
Several different theories have been proposed to explain the CaM-dependent reductase activity of nNOS. Pre-steadystate reduction of the flavins of nNOS by NADPH was shown to be CaM-dependent, indicating that hydride transfer to the FAD was limiting the reductase activity of the enzyme [2, 10] . However, this argument is inconsistent with the higher rate of ferricyanide reduction compared to cytochrome c reduction observed in the CaM-free enzyme. It was also thought that interflavin electron transfer was being accelerated by CaM binding, based on the fact that ferricyanide reduction outpaces cytochrome c reduction in the CaM-free enzyme (Table 1 ) [4] . Note that cytochrome c reacts solely with the FMN cofactor of the enzyme. In either case, the rate of cytochrome c reduction is much higher than the rate of NO synthesis even in the CaM-free enzyme and therefore the overall turnover rate could not be limited by electron transfer through the flavins. In order to resolve these issues, we conducted a series of pre-steadystate reduction and oxidation experiments on nNOSrd using NADPH and cytochrome c as reactants [12] . The stable, oneelectron-reduced form (FMN semiquinone) of nNOSrd was reacted with an excess of NADPH in anaerobic stopped-flow experiments. Instead of observing simple monophasic flavin reduction caused by hydride transfer, both the CaM-bound and CaM-free enzymes yielded complex multiphasic kinetic traces, with fast phases occurring with rates in excess of 400 s −1 . The experiment was repeated using the isolated FAD sub-domain of nNOS generated by trypsinolysis of nNOSrd, giving remarkably similar results. It appears that the reaction of NADPH with nNOS is complicated by a combination of low dissociation rates for NADPH/NADP + and internal, transient redox equilibria in which the hydride is shared between FAD and NADP + . Nevertheless, the fundamental rate constant for hydride transfer is much higher in both the presence and absence of CaM than the rates of turnover with ferricyanide or cytochrome c.
In a second series of experiments, the rate of electron transfer from nNOSrd to cytochrome c was investigated by mixing an excess of anaerobic reduced nNOSrd with a substoichiometric amount of ferricytochrome c. These stoppedflow reactions gave single exponential traces characteristic of first-order kinetic behaviour. Varying the concentration of nNOSrd caused proportional variations in the rate of cytochrome c reduction, from these, second-order rate constants (k 2nd ) were determined ( Figure 2) . The rates of cytochrome c reduction observed are likely to be much lower than the microscopic rates of electron transfer. Instead, the values for k 2nd reflect the rate of association of cytochrome c with the electron-transfer site (FMN) and are an indication of its accessibility. It was found that CaM binding causes k 2nd to increase by 2.5-fold for nNOSrd, suggesting only a modest increase in the accessibility of the FMN for cytochrome c. However, in the presence of NADPH, k 2nd for the CaM-free enzyme dropped by 14-fold. The CaM-bound enzyme was unaffected by the presence of NADPH. Clearly, bound NADPH has a great influence on the conformation of the nNOSrd. To further examine the effects of NADPH and CaM binding, pre-steady-state oxidation experiments were performed in which reduced nNOSrd was oxidized by an excess of cytochrome c. In the absence of NADPH, the number of electron equivalents transferred totalled three, for both the CaM-free and CaMbound enzymes, representing oxidation of the FAD from hydroquinone to quinone (two electrons) and of the FMN from hydroquinone to stable semiquinone (one electron). The rate of transfer was rapid, with oxidation of both flavins occurring within 0.1 s. The results obtained with NADPH-reduced CaM-bound enzyme (eluted through a gel-filtration column to remove excess reductant) were very similar. However, reduction of nNOSrd by NADPH in the absence of CaM yielded a very different enzyme form, which was oxidized much more slowly by cytochrome c. In total, five electron equivalents were transferred to cytochrome c, indicating that a stoichiometric amount of NADPH remained bound to the enzyme following gel filtration. The oxidation followed a monoexponential time course with a rate constant of 4.5 s −1 . Clearly, bound NADPH strongly inhibits the reaction of reduced nNOSrd with cytochrome c in the absence of CaM, making this electron-transfer step rate-determining. It appears that the CaM-dependent reductase activity of nNOS originates from the accessibility of the FMN to external electron acceptors. The same effect is likely to control the rate of electron transfer to the oxygenase domain, explaining the close correlation between CaM-dependent reductase activity and NOS activity. It is ironic that the substrate (NADPH) is the trigger for inactivation of the reductase domain. Its binding energy must be used to lock the enzyme into a conformation in which the FMN is concealed. This is easily envisaged given its direct interaction with the FAD stacking residue (Phe-1395), which in turn is connected to the C-terminal extension [9] , which is likely to interact with the FMN-binding sub-domain and perhaps the autoinhibitory loop [13] . The role of CaM is therefore to unlock the reductase domain by introducing conformational flexibility, enabling the FMN to interact with both the FAD and the haem during catalysis.
